Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy
GastroenterologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Digestive diseases and sciences
- Publicado em
- 27 out 2023
- Citações
- 11
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy
Shiva Poola, MaryKate Kratzer, Kerry Sewell, Hans L Tillmann
Descritores MeSH
- Hepatitis B
- Hepatitis B virus
- Tumor Necrosis Factor Inhibitors
- Humans
- Virus Activation
- Hepatitis B Surface Antigens
- Hepatitis B Antibodies
Veja também
Estudos relacionados
- TNF-α Inhibitors and HBV Reactivation Risk in HBsAg-/Anti-HBc+ Patients: A Systematic Review and Meta-Analysis
- Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment
- Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-Analysis
- What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis